Unknown

Dataset Information

0

USP6NL mediated by LINC00689/miR-142-3p promotes the development of triple-negative breast cancer.


ABSTRACT: BACKGROUND:Triple-negative breast cancer (TNBC), in part because of the high metastasis rate, is one of the most prevalent causes of malignancy-related mortality globally. Ubiquitin specific peptidase 6?N-terminal like (USP6NL) has been unmasked to be implicated in some human cancers. However, the precise biological function of USP6NL in TNBC has not been defined. METHODS:RNA expression was examined by real-time quantitative PCR (RT-qPCR), while USP6NL protein level was tested through western blot. Besides, cell proliferation was assessed by using colony formation assay, whereas cell apoptosis estimated by flow cytometry analysis, JC-1 assay and TUNEL assay. Transwell assays were adopted to detect the migration and invasion of indicated TNBC cells. Immunofluorescence (IF) assay evaluated epithelial-mesenchymal transitions (EMT) progress in TNBC. Further, RNA immunoprecipitation (RIP), RNA pull down and luciferase reporter assays were implemented for measuring the mutual interplay among USP6NL, miR-142-3p and long intergenic non-protein coding RNA 689 (LINC00689). RESULTS:Elevated USP6NL level was uncovered in TNBC cells. RNA interference-mediated knockdown of USP6NL inhibited TNBC cell growth, motility and EMT. Further, USP6NL was proved as the target of a tumor-inhibitor miR-142-3p, and LINC00689 augmented USP6NL expression by absorbing miR-142-3p. Importantly, miR-142-3p deficiency or USP6NL overexpression fully abolished the inhibitory effect of LINC00689 silence on TNBC cellular behaviors. CONCLUSION:All data revealed the important role of USP6NL/LINC00689/miR-142-3p signaling in TNBC. The findings might provide a new and promising therapeutic biomarker for treating patients with TNBC.

SUBMITTER: Ma T 

PROVIDER: S-EPMC7559130 | biostudies-literature | 2020 Oct

REPOSITORIES: biostudies-literature

altmetric image

Publications

USP6NL mediated by LINC00689/miR-142-3p promotes the development of triple-negative breast cancer.

Ma Teng T   Liu Huaidong H   Liu Yan Y   Liu Tingting T   Wang Hui H   Qiao Fulu F   Song Lu L   Zhang Lin L  

BMC cancer 20201014 1


<h4>Background</h4>Triple-negative breast cancer (TNBC), in part because of the high metastasis rate, is one of the most prevalent causes of malignancy-related mortality globally. Ubiquitin specific peptidase 6 N-terminal like (USP6NL) has been unmasked to be implicated in some human cancers. However, the precise biological function of USP6NL in TNBC has not been defined.<h4>Methods</h4>RNA expression was examined by real-time quantitative PCR (RT-qPCR), while USP6NL protein level was tested thr  ...[more]

Similar Datasets

| S-EPMC5738224 | biostudies-literature
| S-SCDT-10_15252-EMMM_202216033 | biostudies-other
| S-EPMC9832842 | biostudies-literature
| S-EPMC7384220 | biostudies-literature
| S-EPMC8802436 | biostudies-literature
| S-EPMC7491078 | biostudies-literature
| S-EPMC8917722 | biostudies-literature
| S-EPMC7581818 | biostudies-literature
| S-EPMC10867422 | biostudies-literature
| S-EPMC7705184 | biostudies-literature